IL177354A0 - Alpha-emitting hydroxyapatite particles - Google Patents

Alpha-emitting hydroxyapatite particles

Info

Publication number
IL177354A0
IL177354A0 IL177354A IL17735406A IL177354A0 IL 177354 A0 IL177354 A0 IL 177354A0 IL 177354 A IL177354 A IL 177354A IL 17735406 A IL17735406 A IL 17735406A IL 177354 A0 IL177354 A0 IL 177354A0
Authority
IL
Israel
Prior art keywords
alpha
hydroxyapatite particles
emitting
emitting radionuclide
emitting hydroxyapatite
Prior art date
Application number
IL177354A
Other versions
IL177354A (en
Original Assignee
Algeta Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2005/000616 external-priority patent/WO2005079867A2/en
Application filed by Algeta Asa filed Critical Algeta Asa
Publication of IL177354A0 publication Critical patent/IL177354A0/en
Publication of IL177354A publication Critical patent/IL177354A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

The present invention provides Hydroxyapatite (HA) incorporating an alpha-emitting radionuclide or an in vivo generator for an alpha-emitting radionuclide. The invention further provides methods for the formation of such HA, pharmaceutical compositions comprising the HA and methods of medical treatment of cancerous or non-cancerous disease including administering the HA or compositions thereof.
IL177354A 2004-02-20 2006-08-08 Alpha-emitting hydroxyapatite particles IL177354A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0403856.8A GB0403856D0 (en) 2004-02-20 2004-02-20 Composition
PCT/GB2005/000616 WO2005079867A2 (en) 2004-02-20 2005-02-18 Alpha-emitting hydroxyapatite particles

Publications (2)

Publication Number Publication Date
IL177354A0 true IL177354A0 (en) 2006-12-10
IL177354A IL177354A (en) 2013-04-30

Family

ID=32040119

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177354A IL177354A (en) 2004-02-20 2006-08-08 Alpha-emitting hydroxyapatite particles

Country Status (13)

Country Link
JP (1) JP5214884B2 (en)
KR (2) KR20070038030A (en)
CN (1) CN1972720B (en)
AT (1) ATE544492T1 (en)
DK (1) DK1735013T3 (en)
ES (1) ES2382041T3 (en)
GB (1) GB0403856D0 (en)
IL (1) IL177354A (en)
NO (1) NO20064232L (en)
NZ (1) NZ549080A (en)
PT (1) PT1735013E (en)
TW (1) TWI347194B (en)
ZA (1) ZA200606728B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE034806T2 (en) * 2015-07-03 2018-02-28 Oncoinvent As Radiotherapeutic particles and suspensions
US20170065731A1 (en) * 2015-09-06 2017-03-09 Medical Theranostics Inc. Method, Apparatus, and System for Radiation Therapy
CN106344927A (en) * 2016-09-27 2017-01-25 大连理工大学 Folate-modified medicine-carrying hydroxylapatite and preparation method thereof
WO2024146921A1 (en) * 2023-01-05 2024-07-11 Oncoinvent As Alpha-emitting radionuclides for use in the treatment of peritoneal cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168015T1 (en) * 1990-12-21 1998-07-15 Mallinckrodt Medical Inc RADIONUCLEOTIDE LABELED PARTICLES USEFUL FOR RADIATION SYNOVECTOMY
CA2174928C (en) * 1993-10-26 2011-08-16 Scott A. Waldman Compositions that specifically bind to colorectal cancer cells and methods of using the same
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
MXPA02003891A (en) * 1999-10-18 2002-12-09 Ferx Inc Magnetic targeted carrier.
JP3836444B2 (en) * 2002-05-30 2006-10-25 独立行政法人科学技術振興機構 Hydroxyapatite composite, method for producing the same, and medical material using the same

Also Published As

Publication number Publication date
ATE544492T1 (en) 2012-02-15
IL177354A (en) 2013-04-30
TWI347194B (en) 2011-08-21
ES2382041T3 (en) 2012-06-04
ZA200606728B (en) 2007-12-27
NZ549080A (en) 2011-01-28
GB0403856D0 (en) 2004-03-24
CN1972720B (en) 2010-07-07
JP2007528373A (en) 2007-10-11
TW200536558A (en) 2005-11-16
NO20064232L (en) 2006-09-19
KR20100060029A (en) 2010-06-04
KR20070038030A (en) 2007-04-09
DK1735013T3 (en) 2012-05-21
CN1972720A (en) 2007-05-30
PT1735013E (en) 2012-05-08
JP5214884B2 (en) 2013-06-19
KR101165518B1 (en) 2012-07-16

Similar Documents

Publication Publication Date Title
WO2005079867A3 (en) Alpha-emitting hydroxyapatite particles
LUC00011I2 (en)
SG166775A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
IL177354A0 (en) Alpha-emitting hydroxyapatite particles

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees